The Role Of Macrophage Senescence In Cardiovascular Diseases
As we age, our bodies undergo many changes, and sometimes, even our immune cells start to show signs of wear and tear. This paper explores how a specific type of immune cell, called a macrophage, can become “senescent.” Think of senescent cells as “zombie cells”—they stop dividing but don’t die off. Instead, they hang around and release harmful substances.
These senescent macrophages are a major factor linking aging to the onset and worsening of cardiovascular diseases, which are conditions affecting the heart and blood vessels, like heart attacks and strokes. When macrophages become senescent, they start to release a cocktail of inflammatory chemicals, enzymes, and signaling molecules. This harmful mix, known as the senescence-associated secretory phenotype (SASP), fuels chronic inflammation and oxidative stress, damaging blood vessels and contributing to the buildup of plaque in arteries, a process called atherosclerosis.
Understanding how these aging macrophages contribute to conditions like atherosclerosis, myocardial infarction (heart attack), and chronic heart failure is critical. The research highlights the underlying molecular mechanisms, such as DNA damage and mitochondrial dysfunction, that drive this cellular aging.
The exciting part is that by identifying the role of these senescent macrophages, scientists are now exploring new therapeutic strategies. The goal is to either eliminate these harmful “zombie” cells or modify their behavior to prevent and treat cardiovascular diseases, offering a new avenue for improving heart health as we get older.
Source: link to paper